MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    The pandemic stress impact on disease progression in COVID-19 seronegative patients with idiopathic Parkinson’s Disease.

    M. Hansen, T. Marques, C. Pauly, L. Delacour, C. Martin-Gallausiaux, P. Wilmes, R. Krüger, N J. Diederich (Strassen, Luxembourg)

    Objective: To investigate the impact of chronic stress (CS) induced by the present pandemic on the progression rates of motor and cognitive impairment, on neuro-inflammatory…
  • MDS Virtual Congress 2021

    The PRIME Qual study protocol: A qualitative exploration of the experiences of patients, caregivers/families and hospital/intervention staff of the PRIME Randomised Controlled Trial

    H. Brant, E. Henderson, D. Gervaise-Brazier, F. Lithander, E. Tenison, S. Redwood (Bristol, United Kingdom)

    Objective: This qualitative study seeks to  understand how a new model of care influences a person with Parkinson’s ability to stay well physically, maintain their…
  • MDS Virtual Congress 2021

    Subjective cognitive complaints assessed with the cognitive domain of the Non-Motor Symptoms Scale predict longitudinal cognitive trajectory in people with Parkinson’s disease with normal cognition

    L. Batzu, DJ. van Wamelen, D. Urso, V. Leta, A. Podlewska, K. Rukavina, J. Staunton, YM. Wan, A. Rizos, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To investigate whether subjective cognitive complaints assessed by the Non-Motor Symptoms Scale (NMSS) are predictive of longitudinal cognitive trajectories in cognitively intact people with…
  • MDS Virtual Congress 2021

    Emotional and cognitive information processing in obstacle negotiation in patient with Parkinson’s disease and freezing

    S. Mezzarobba, M. Grassi, E. Pelosin, P. Manganotti, P. Bernardis (Genova, Italy)

    Objective: We used emotional (images from the International Affective Picture System - IAPS)1 and cognitive inputs(visual perturbation in a stepping-over-the-obstacle task) with the aim to…
  • MDS Virtual Congress 2021

    THE ABILITY OF PATIENTS WITH PARKINSON’S DISEASE TO RECOGNIZE MASKED FACES DURING COVID-19 PANDEMIC

    S. Tezcan Aydemir, M. Kuzu Kumcu, N. Durmaz çelik, B. Bakirarar, S. özkan, M. Akbostancı (Ankara, Turkey)

    Objective: This study aims to evaluate the effect of using masks on face recognition ability in Patients with Parkinson’s disease (PwP). Background: Patients with Parkinson’s…
  • MDS Virtual Congress 2021

    Novel PLA2G6 Mutation Presenting as Early-Onset Parkinson’s Disease

    J. Hislop, E. Saraf Lavi, D. Barbouth, M. Foley, H. Moore, C. Singer (Miami, USA)

    Objective: To report a case of a novel mutation in the PLA2G6 gene resulting in early-onset Parkinson’s Disease. Background: The phospholipase A2 group VI (PLA2G6)…
  • MDS Virtual Congress 2021

    Ultrastructural Characterization of Monocytes in Parkinson’s Disease and GBA mutations

    GM. Riboldi, S. Dilipkumar, A. Sowa, A. Allen, K. Astudillo, J. Crary, S. Frucht, T. Raj, W. Janseen (New York, USA)

    Objective: To identify morphological changes in circulating CD14+ monocytes in manifesting and non-manifesting carriers of mutations of the GBA gene and Parkinson’s disease (PD). Background: Mutations of…
  • MDS Virtual Congress 2021

    Antioxidants in foods: A Primary Potential remedy to Neurodegeneration.

    B. Adebisi (Osogbo, Nigeria)

    Objective: The aim of the research is to establish the plausibility of reducing the effects of the actions of reactive oxygen species, produced by glutamate…
  • MDS Virtual Congress 2021

    Biofluid Biomarkers in Prodromal Parkinson’s Disease

    B. Mollenhauer, L. Chahine, M. Dakna, M. Bartl, A. Siderowf, SJ. Hutten, K. Merchant, K. Marek, D. Galasko (Kassel, Germany)

    Objective: To analyze biomarker signatures in biofluids in prodromal Parkinson’s disease (PD) to identify subjects at-risk to conversion and for progression. Background: Individuals at-risk for…
  • MDS Virtual Congress 2021

    Longitudinal change in thalamic white matter macrostructure and volume in Parkinson’s disease depression

    R. Bhome, A. Zarkali, J. Cole, R. Weil (London, United Kingdom)

    Objective: To investigate thalamic subnuclei volume and macrostructural white matter changes in Parkinson’s disease (PD) depression. Background: Depression is the most common neuropsychiatric feature of…
  • « Previous Page
  • 1
  • …
  • 528
  • 529
  • 530
  • 531
  • 532
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley